Alcon Inc. (SWX:ALC)
75.38
-0.36 (-0.48%)
Apr 17, 2025, 5:31 PM CET
Alcon Revenue
In the year 2024, Alcon had annual revenue of $9.91B USD with 4.82% growth. Alcon had revenue of $2.50B in the quarter ending December 31, 2024, with 6.38% growth.
Revenue
$9.91B
Revenue Growth
+4.82%
P/S Ratio
4.15
Revenue / Employee
$387.16K
Employees
25,599
Market Cap
37.28B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.91B | 456.00M | 4.82% |
Dec 31, 2023 | 9.46B | 738.00M | 8.47% |
Dec 31, 2022 | 8.72B | 426.00M | 5.14% |
Dec 31, 2021 | 8.29B | 1.46B | 21.34% |
Dec 31, 2020 | 6.83B | -675.00M | -8.99% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Novartis AG | 46.87B |
Lonza Group AG | 6.57B |
Galderma Group AG | 4.02B |
Straumann Holding AG | 2.50B |
Sandoz Group AG | 9.41B |
Sonova Holding AG | 3.71B |
Ypsomed Holding AG | 617.07M |
Alcon News
- 6 days ago - Alcon proposes CHF 0.28 dividend - Seeking Alpha
- 7 days ago - Alcon: A Clear Vision, But Fully Valued - Seeking Alpha
- 14 days ago - Alcon Inc (ALC) Announces Upcoming Annual General Meeting and Board Changes - GuruFocus
- 14 days ago - Alcon Publishes Agenda for 2025 Annual General Meeting - Business Wire
- 14 days ago - Alcon Publishes Agenda for 2025 Annual General Meeting - Business Wire
- 15 days ago - Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter - Business Wire
- 22 days ago - Alcon buys majority stake in Aurion Biotech - Seeking Alpha
- 22 days ago - Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease - Business Wire